Answers are grounded in this paper and cite their sources.
PURPOSE: Individual responses to speech treatment in Parkinson's disease (PD) vary widely, yet few studies have investigated which pretreatment factors predict these differences. This study investigated whether baseline speaking rate predicts communicative effectiveness following SPEAK OUT! treatment and whether this effect is driven by articulatory rate, pausing, or both. METHOD: Fifty-three adults with PD completed the SPEAK OUT! Therapy Program, which included 4 weeks of individual therapy and 5 weeks of group maintenance sessions. Speaking rate (syllables per second) was computed from read sentences during three pretreatment sessions, and communicative effectiveness was assessed using the Communicative Effectiveness Survey (CES) across pretreatment, post-individual treatment, and post-group treatment phases. Linear mixed-effects models tested whether speaking rate predicted CES change across treatment phases, with sensitivity analyses adjusting for age, sex, dysarthria severity, and treatment frequency. An exploratory subgroup analysis compared outcomes between participants with slower and faster pretreatment speaking rates. RESULTS: CES scores improved significantly following individual treatment, and gains were maintained post-group treatment. Baseline speaking rate significantly predicted CES outcomes, with slower speakers showing greater CES improvement, even when controlling for dysarthria severity. Exploratory subgroup analyses revealed that faster speakers showed larger acoustic changes but smaller CES gains, while slower speakers showed minimal acoustic change but larger CES gains. Articulatory rate emerged as a stronger main effect predictor of CES than pause time, though the two components of speaking rate could not be reliably distinguished as separate moderators of treatment response. DISCUSSION: Speaking rate is a clinically accessible predictor of communicative effectiveness outcomes following SPEAK OUT! in PD. These findings suggest that acoustic assessment may be a useful complement to clinical and self-report measures in pretreatment planning.
No takes yet. Share an insight, caveat, or question.
Rowe et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: